Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Funakoshi

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Pancreas|June 29, 2006
Association of SH-2 containing inositol 5'-phosphatase 2 gene polymorphisms and hyperglycemiaSatoru Ishida, Akihiro Funakoshi, Kyoko Miyasaka, et al.
Obesity Research|September 2, 2004
Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gainMichiko Koda, Fujiko Ando, Naoakira Niino, et al.
Endocrine Pathology|April 1, 1995
Immunohistochemical Localization of Chromostatin and Pancreastatin, Chromogranin A-Derived Bioactive Peptides, in Normal and Neoplastic Neuroendocrine TissuesNoriko Kimura, Akihiro Funakoshi, Dominique Aunis, et al.
The Journal of Physiological Sciences : JPS|December 1, 2006
Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient miceChihiro Sakurai, Minoru Ohta, Setsuko Kanai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1]Chinatsu Fujimoto, Yuji Maruyama, Yuusuke Niina, et al.
Biomedical Research (Tokyo, Japan)|December 27, 2011
Administration of ursodeoxycholate failed to prevent sludge and/or gallstone formation in cholecystokinin-1(A) receptor-deficient miceNobuko Nihei, Ayako Sekime, Kyoko Miyasaka, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2007
A late phase II study of S-1 for metastatic pancreatic cancerTakuji Okusaka, Akihiro Funakoshi, Junji Furuse, et al.
Journal of Gastroenterology|November 9, 2002
Promoter analysis of human cholecystokinin type-A receptor geneYutaka Takata, Shigeki Takeda, Takako Kawanami, et al.
Journal of Pharmacological Sciences|August 8, 2006
Disturbance of response to acute thermal pain in naturally occurring cholecystokinin-a receptor gene knockout Otsuka Long-Evans Tokushima Fatty (OLETF) ratsKyoko Miyasaka, Shigeki Nomoto, Minoru Ohta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[A case of pancreatic well-differentiated neuroendocrine carcinoma surviving 8 years and 5 months with treatments for multiple liver tumors diagnosed as carcinoid tumor]Yukihiko Okumura, Rie Sugimoto, Kenichi Taguchi, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Pancreas|June 29, 2006
Association of SH-2 containing inositol 5'-phosphatase 2 gene polymorphisms and hyperglycemiaSatoru Ishida, Akihiro Funakoshi, Kyoko Miyasaka, et al.
Obesity Research|September 2, 2004
Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gainMichiko Koda, Fujiko Ando, Naoakira Niino, et al.
Endocrine Pathology|April 1, 1995
Immunohistochemical Localization of Chromostatin and Pancreastatin, Chromogranin A-Derived Bioactive Peptides, in Normal and Neoplastic Neuroendocrine TissuesNoriko Kimura, Akihiro Funakoshi, Dominique Aunis, et al.
The Journal of Physiological Sciences : JPS|December 1, 2006
Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient miceChihiro Sakurai, Minoru Ohta, Setsuko Kanai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1]Chinatsu Fujimoto, Yuji Maruyama, Yuusuke Niina, et al.
Biomedical Research (Tokyo, Japan)|December 27, 2011
Administration of ursodeoxycholate failed to prevent sludge and/or gallstone formation in cholecystokinin-1(A) receptor-deficient miceNobuko Nihei, Ayako Sekime, Kyoko Miyasaka, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2007
A late phase II study of S-1 for metastatic pancreatic cancerTakuji Okusaka, Akihiro Funakoshi, Junji Furuse, et al.
Journal of Gastroenterology|November 9, 2002
Promoter analysis of human cholecystokinin type-A receptor geneYutaka Takata, Shigeki Takeda, Takako Kawanami, et al.
Journal of Pharmacological Sciences|August 8, 2006
Disturbance of response to acute thermal pain in naturally occurring cholecystokinin-a receptor gene knockout Otsuka Long-Evans Tokushima Fatty (OLETF) ratsKyoko Miyasaka, Shigeki Nomoto, Minoru Ohta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[A case of pancreatic well-differentiated neuroendocrine carcinoma surviving 8 years and 5 months with treatments for multiple liver tumors diagnosed as carcinoid tumor]Yukihiko Okumura, Rie Sugimoto, Kenichi Taguchi, et al.
Pageof 9